Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
freedom_of_information:a-2021-000129 [2023/03/20 03:17]
liam [Therapeutics] | freedom_of_information:a-2021-000129 [2023/03/20 03:17] (current)
liam [Therapeutics] |
|---|
| | [[:Ivermectin]] | Stromectol, Mectizan | - | [[pharmaceutical_companies:Merck]] | Administered intravenously (IV) and orally in studies for the treatment of [[:COVID-19]]. Authorized by [[:Health Canada]] for the treatment of parasitic infections in humans and animals. Indicated in humans for the treatment of [[:intestinal strongyloidiasis]] and [[:onchoceriasis]]/rosacea. Not recommended for use outside of clinical trials. | | | [[:Ivermectin]] | Stromectol, Mectizan | - | [[pharmaceutical_companies:Merck]] | Administered intravenously (IV) and orally in studies for the treatment of [[:COVID-19]]. Authorized by [[:Health Canada]] for the treatment of parasitic infections in humans and animals. Indicated in humans for the treatment of [[:intestinal strongyloidiasis]] and [[:onchoceriasis]]/rosacea. Not recommended for use outside of clinical trials. | |
| | [[:Melatonin]] | - | - | - | - | | | [[:Melatonin]] | - | - | - | - | |
| | [[:Molnupiravir]] | MK-4482 | [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Ridgeback Pharmaceuticals]] | - | | | [[:Molnupiravir]] | - | MK-4482 | [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Ridgeback Pharmaceuticals]] | - | |
| | [[:Lopinavir/ritonavir]] | Kaletra | - | [[pharmaceutical_companies:AbbVie]] | [[:HIV]]/[[:acquired_immune_deficiency_syndrome|AIDS]] drug | | | [[:Lopinavir/ritonavir]] | Kaletra | - | [[pharmaceutical_companies:AbbVie]] | [[:HIV]]/[[:acquired_immune_deficiency_syndrome|AIDS]] drug | |
| | [[:Quercetin]] | - | - | - | - | | | [[:Quercetin]] | - | - | - | - | |
